Alembic Pharmaceuticals Limited (NSE:APLLTD)
India flag India · Delayed Price · Currency is INR
821.75
+7.65 (0.94%)
Aug 21, 2026, 3:30 PM IST

Alembic Pharmaceuticals Stock Forecast

Stock Price Forecast

According to 10 analysts polled by S&P Global, Alembic Pharmaceuticals stock has a consensus rating of "Buy" and an average price target of ₹949.30. The average 1-year stock price forecast is 15.52% higher than the current stock price, while the lowest is ₹800.00 (-2.65%) and the highest is ₹1,132 (+37.75%).

Price Target: ₹949.30 (+15.52%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price₹800.00₹949.30₹901.50₹1,132
Change-2.65%+15.52%+9.70%+37.75%

Analyst Ratings

The average analyst rating for Alembic Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingJan '26Feb '26Apr '26May '26Jul '26Aug '26
Strong Buy555444
Buy222222
Hold433333
Sell000000
Strong Sell111111
Total121111101010

Financial Forecast

Revenue This Year
84.17B
from 73.45B
Increased by 14.60%
Revenue Next Year
92.45B
from 84.17B
Increased by 9.84%
EPS This Year
36.99
from 37.62
Decreased by -1.69%
EPS Next Year
48.02
from 36.99
Increased by 29.83%
Fiscal YearFY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingMar 31, 2022Mar 31, 2023Mar 31, 2024Mar 31, 2025Mar 31, 2026Mar 31, 2027
Revenue
53.06B56.53B62.29B66.72B73.45B84.17B
Revenue Growth
-1.62%6.54%10.19%7.12%10.08%14.60%
Gross Profit
38.08B38.78B44.33B47.91B52.66B60.76B
Gross Margin
71.76%68.60%71.16%71.81%71.70%72.18%
Operating Income
5.87B4.38B6.61B7.30B7.97B9.76B
Net Income
5.21B3.42B6.16B5.83B6.75B7.32B
EPS
----37.6236.99
EPS Growth
----29.11%-1.69%
Forward PE
19.7619.1528.7125.3716.1522.22
Dividend / Share
10.008.0011.0011.0012.0012.87
Dividend Growth
-28.57%-20.00%37.50%-9.09%7.23%
Free Cash Flow
-324.73M504.46M2.20B-7.27B203.49M3.30B
No. Analysts
-----9
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.

Revenue Forecast

Revenue202720282029
High87.1B
Avg84.2B
Low82.7B

Revenue Growth

Revenue Growth202720282029
High
18.6%
Avg
14.6%
Low
12.6%

EPS Forecast

EPS202720282029
High41.50
Avg36.99
Low34.30

EPS Growth

EPS Growth202720282029
High
10.3%
Avg
-1.7%
Low
-8.8%